4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-23-013286
Options or other derivatives
- President and CEO acquired 160,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Tesi Raymond Joseph · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-16 | Grant or award : show line 1 in the form Option (right to buy) | +160,000 | 160,000 | D |
Loading xslF345X03/ownership.xml…